Anti Cancer Medicines
Showing 17–32 of 38 results
-
LYNPARZA (olaparib) tablets
Read more -
NUBEQA (darolutamide) tablets, for oral use. Initial U.S. Approval: 2019
Read more -
OGSIVEO (nirogacestat) tablets
Read more -
ORSERDU (elacestrant) tablets
Read more -
PARSABIV (etelcalcetide) injection, for intravenous use. Initial U.S. Approval: 2017
Read more -
Pemrydi RTU (pemetrexed disodium) injection
Read more -
POSLUMA (flotufolastat F 18)
Read more -
RETEVMO (selpercatinib) capsules
Read more -
ROLVEDON (eflapegrastim-xnst) injection
Read more -
TEPEZZA (teprotumumab-trbw) for injection, for intravenous use Initial U.S. Approval: 2020
Read more -
TERLIVAZ (terlipressin) for injection
Read more -
TEVIMBRA (tislelizumab-jsgr) injection
Read more -
TRIKAFTA (elexacaftor, tezacaftor and ivacaftor tablets; ivacaftor tablets), co-packaged for oral use. Initial U.S. Approval: 2019
Read more -
TRUQAP (capivasertib) tablets
Read more -
Valamor (Ribociclib) Tablets
Read more -
VEGZELMA (bevacizumab-adcd) injection
Read more
